Interferon Beta-1A

Trial of Treatments for COVID-19 in Hospitalized Adults

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients

A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza

Adaptive COVID-19 Treatment Trial 3 (ACTT-3)

Public Health Emergency: SOLIDARITY TRIAL Philippines

World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments

Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis

Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA

Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)

Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy

Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic

An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial

Interferon Beta 1a in Hospitalized COVID-19 Patients